Episode 8. Management of Newly Diagnosed CLL
Blood Cancer Talks
00:00
The Future of MRD Assessment
The flow remains the standard, I guess, MRD assessment too, which is used most commonly. But now we are moving away from bone marrow MRD to blood MRD because obviously it's much more convenient for the patient and you can track it serially,. You know, closely. All right, and what time point, I know it depends on treatment. For example, if you were treating a patient with a Calibriutinib, you would not be checking MRD in those patients. So then, you know, so again, one could argue that you don't need to do MRD. It's too complicated. What are you going to act on the MRD
Transcript
Play full episode
